Phenoxyalkycarboxylic acid derivatives in the treatment of ulcerative colitis

Abstract

A method of treating ulcerative colitis in a patient suffering therefrom comprising: administering an effective amount of a compound selected from compound 1, its metabolite 2 and pharmaceutically acceptable salts or esters thereof:

1. A method of treating ulcerative colitis in a patient suffering therefrom, comprising: administering an effective amount of compound (1) 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt or an ester thereof. 
     
     
       2. The method of  claim 1 , wherein the compound is administered orally. 
     
     
       3. The method of  claim 2 , wherein the dosage form is a tablet or capsule. 
     
     
       4. The method of  claim 1 , wherein the compound is present in polymorphic Form A and is substantially free of other polymorphic forms. 
     
     
       5. The method of  claim 1 , wherein the compound is administered in a liquid. 
     
     
       6. The method of  claim 1 , wherein the dose is from 250 to 2,500 mg/day, divided into one, two or three portions. 
     
     
       7. The method of  claim 1 , wherein the compound is present as orthorhombic crystals. 
     
     
       8. The method of  claim 1 , further comprising administration of compound (2) 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt or an ester thereof. 
     
     
       9. A method of treating ulcerative colitis in a patient suffering therefrom, comprising: administering an effective amount of compound (2) 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt or an ester thereof.